Genomic and Demographic Characteristics of Angiosarcoma as Described in the AACR Project GENIE Registry
Open Access
Abstract
Background: Despite the high mortality associated with angiosarcoma, its low prevalence has limited sample sizes in prior studies. To address these gaps, we analyzed the AACR Project GENIE registry, a large, multi-institutional database. Methods: 359 tumor samples from 346 patients with angiosarcoma were identified from the AACR Project GENIE v18.0-public database using cBioPortal. Somatic mutations and copy number alterations were assessed. Statistical significance was assessed by t-test for continuous variables and a chi-squared test for categorical data, with significance set at p < 0.05. Results: Recurrent mutations included TP53 (20.6%), KDR (13.6%), and PIK3CA (10.6%). Copy number alterations occurred in MYC (27.3%), CRKL (10.4%), FLT4 (5.5%), and KDR (4.8%). Homozygous deletions occurred in CDKN2A (6.6%), CDKN2B (6.56%), and MTAP (3.81%). Significant co-occurrence included FAT1-NOTCH2, TP53-ATRX, and NOTCH1-ARID1A. Mutual exclusivity was seen with KDR-FLT4 and KDR-ATRX. Females exhibited enrichment in MYC and HRAS, while males exhibited enrichment in POT1, NTRK2, and FAT1. Compared with primary tumors, metastatic tumors more often displayed ZFHX4, FGFR1, MSI2, HIST1H1C, and TOP1 mutations, while MAPK7 mutations occurred only in primary tumors. Conclusions: In one of the largest genomic analyses of angiosarcoma to date, we identified recurrent alterations, suggesting potential future therapeutic targets.Keywords
This publication has 54 references indexed in Scilit:
- Angiosarcoma: Role of ImmunotherapyCurrent Treatment Options in Oncology, 2025
- Demographics, Prognostic Factors, and Survival Outcomes in Hepatic Angiosarcoma: A Retrospective AnalysisJournal of Gastrointestinal Cancer, 2024
- Genomic landscape and preclinical models of angiosarcomaMolecular Oncology, 2024
- Incidence and Presenting Characteristics of Angiosarcoma in the US, 2001-2020JAMA Network Open, 2024
- The roles of EZH2 in cancer and its inhibitorsMedical Oncology, 2023
- Strong radioprotective FGF1 signaling down-regulates proliferative and metastatic capabilities of the angiosarcoma cell line, ISOS-1, through the dual inhibition of EGFR and VEGFR pathwaysClinical and Translational Radiation Oncology, 2017
- γ-Secretase inhibitors and modulatorsBiochimica et Biophysica Acta (BBA) - Biomembranes, 2013
- Cutaneous angiosarcoma. Analysis of 434 cases from the Surveillance, Epidemiology, and End Results Program, 1973-2007Annals of Diagnostic Pathology, 2011
- Consistent MYC and FLT4 gene amplification in radiation‐induced angiosarcoma but not in other radiation‐associated atypical vascular lesionsGenes, Chromosomes and Cancer, 2010
- Incidence patterns of soft tissue sarcomas, regardless of primary site, in the surveillance, epidemiology and end results program, 1978–2001: An analysis of 26,758 casesInternational Journal of Cancer, 2006